Fabrazyme 35 MG vials
Ended Awarded
- Contract number
- SPE2DB25FY23H
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,735
Award facts
- Contract value 100% obligated
- $25,734.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $25,734.92 by the Defense Logistics Agency (DLA) on September 15, 2025, for the supply of Fabrazyme 35 mg vials. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The contract carries no set-aside designation, allowing the woman-owned small business to compete directly in the federal procurement marketplace. Performance will be completed by October 6, 2025, at the company's location in Park Ridge, Illinois.
Fabrazyme is a specialty pharmaceutical product used in the treatment of Fabry disease, a rare genetic disorder. As a crucial supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides direct distribution of prescription drugs and specialty medications to Department of Defense healthcare facilities nationwide. This delivery order represents one of numerous pharmaceutical procurements the company has secured through its IDC with DLA, which encompasses an extensive portfolio including branded and generic prescription drugs, biologics, and medical consumables supporting military health facility operations globally.
Quick answers
Who was awarded contract SPE2DB25FY23H?
SPE2DB25FY23H was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FY23H worth?
The government has obligated $25,735 on SPE2DB25FY23H.
Is contract SPE2DB25FY23H an order under another contract?
Yes. SPE2DB25FY23H is a delivery order under SPE2DB22D9362, an indefinite delivery contract.
Was contract SPE2DB25FY23H competed?
The extent of competition for SPE2DB25FY23H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award